Below is a comprehensive, publication-ready master’s level research proposal, written in formal academic style and structured to meet the expectations of thesis supervisors, examination committees, and postgraduate review boards. It is designed to be directly usable as a final year project proposal with minimal modification. Proposed Research Title Leveraging Blockchain Technology to Enhance Supply Chain Transparency in the Pharmaceutical Industry: A Framework for Traceability, Trust, and Anti-Counterfeiting Research Focus Overview The pharmaceutical supply chain is among the most complex and highly regulated global supply networks, yet it remains vulnerable to inefficiencies, opacity, and the circulation of counterfeit medicines. This research investigates how blockchain technology can be applied to enhance transparency, traceability, and trust within pharmaceutical supply chains. By examining blockchain-enabled supply chain systems, this study aims to develop a conceptual and practical framework that demonstrates how distributed ledger technologies can address persistent challenges related to data integrity, visibility, and accountability in pharmaceutical logistics. The research contributes to both academic discourse and industry practice by providing evidence-based insights into the feasibility, benefits, and limitations of blockchain adoption in this critical sector. 1. Background and Context Supply chain transparency has become a central concern in the pharmaceutical industry due to increasing globalization, regulatory pressure, and rising incidents of counterfeit and substandard medicines. According to global health organizations, counterfeit pharmaceuticals pose significant risks to patient safety, erode public trust, and result in substantial economic losses for manufacturers and governments. Traditional pharmaceutical supply chains rely on centralized databases and fragmented information systems, which often lack interoperability, real-time visibility, and tamper resistance. Blockchain technology—characterized by decentralization, immutability, cryptographic security, and distributed consensus—has emerged as a promising solution for addressing transparency and traceability challenges across complex supply chains. In recent years, scholars and industry practitioners have explored blockchain applications in logistics, food safety, finance, and healthcare. Within the pharmaceutical domain, blockchain has been proposed as a tool for tracking drug provenance, preventing counterfeiting, ensuring regulatory compliance, and improving stakeholder trust. Despite growing interest, existing research remains fragmented. Many studies are conceptual, technology-driven, or limited to pilot implementations without systematic evaluation of transparency outcomes. Furthermore, there is limited empirical and framework-based research that integrates technological, organizational, and regulatory perspectives specific to pharmaceutical supply chains. This gap underscores the need for structured academic inquiry that critically examines how blockchain can be operationalized to enhance transparency while considering real-world constraints such as cost, scalability, governance, and regulatory alignment. This study responds to contemporary challenges in pharmaceutical supply chain management by situating blockchain technology within established supply chain transparency theories and proposing a structured approach for its adoption and evaluation. 2. Problem Statement Despite advancements in supply chain management systems, the pharmaceutical industry continues to struggle with limited transparency, fragmented data sharing, and vulnerability to counterfeit products. Existing supply chain infrastructures are largely centralized and siloed, making them prone to data manipulation, lack of real-time visibility, and trust deficits among stakeholders. While blockchain technology has been widely promoted as a solution to these issues, there is insufficient academic evidence detailing how, to what extent, and under what conditions blockchain can effectively enhance transparency in pharmaceutical supply chains. The core problem addressed in this research is the absence of a clear, empirically grounded, and context-specific framework that explains the role of blockchain technology in improving supply chain transparency within the pharmaceutical industry. Without such understanding, organizations face uncertainty regarding adoption decisions, implementation strategies, and expected outcomes, limiting the practical impact of blockchain innovations. 3. Research Objectives The primary objective of this research is to examine the application of blockchain technology in enhancing supply chain transparency within the pharmaceutical industry. The specific objectives are to: Analyze the transparency challenges present in traditional pharmaceutical supply chains. Examine the key features of blockchain technology relevant to supply chain transparency and traceability. Investigate current and emerging blockchain-based applications in pharmaceutical supply chains. Assess the perceived benefits and challenges of blockchain adoption from a supply chain transparency perspective. Develop a conceptual framework outlining how blockchain technology can enhance pharmaceutical supply chain transparency. 4. Research Questions To achieve the stated objectives, this study will be guided by the following research questions: What are the major transparency and traceability challenges in traditional pharmaceutical supply chains? Which characteristics of blockchain technology are most relevant to improving supply chain transparency? How is blockchain currently being applied within pharmaceutical supply chains? What benefits and limitations are associated with blockchain-enabled transparency in the pharmaceutical industry? How can a structured framework be developed to guide the effective adoption of blockchain for pharmaceutical supply chain transparency? 5. Literature Review Framework The literature review will be thematically structured around the following key areas: 5.1 Pharmaceutical Supply Chain Transparency This section will examine traditional pharmaceutical supply chain structures, transparency concepts, regulatory requirements (e.g., serialization and track-and-trace), and the implications of information asymmetry and counterfeit medicines. 5.2 Blockchain Technology Foundations This section will review the theoretical foundations of blockchain technology, including distributed ledger systems, smart contracts, consensus mechanisms, and data immutability, drawing from information systems and technology management literature. 5.3 Blockchain in Supply Chain Management This section will analyze existing research on blockchain applications in supply chain management, focusing on transparency, traceability, trust, and coordination among stakeholders. 5.4 Blockchain Applications in the Pharmaceutical Industry This section will synthesize studies, pilot projects, and industry reports on blockchain-based pharmaceutical supply chains, highlighting successes, challenges, and unresolved debates. 5.5 Identified Research Gaps The final subsection will critically evaluate gaps in current scholarship, particularly the lack of integrated frameworks and sector-specific empirical analysis, thereby positioning the present study. 6. Research Methodology 6.1 Research Approach This study will adopt a qualitative research approach, supported by exploratory and descriptive analysis. A qualitative design is appropriate given the emerging nature of blockchain adoption in pharmaceutical supply chains and the need to understand contextual, organizational, and technological factors. 6.2 Research Design The research will employ a systematic literature review combined with case-based analysis of documented blockchain implementations in pharmaceutical supply chains. 6.3 Data Collection Methods Peer-reviewed journal articles Industry reports and white papers Regulatory documents Documented case studies of blockchain pilots and implementations 6.4 Data Analysis Techniques Thematic analysis will be used to identify recurring patterns, themes, benefits, challenges, and implementation factors related to blockchain-enabled transparency. 6.5 Validity, Reliability, and Ethics Use of reputable academic databases (Scopus, Web of Science, IEEE Xplore) Transparent inclusion and exclusion criteria Proper citation and avoidance of plagiarism Ethical handling of secondary data sources This methodology is feasible within a master’s thesis timeframe and does not require primary data collection, reducing ethical and logistical constraints. 7. Significance and Contribution Academic Contribution This research contributes to the academic literature by synthesizing blockchain and pharmaceutical supply chain scholarship into a structured transparency-focused framework. It advances theoretical understanding of how emerging technologies influence supply chain governance and trust mechanisms. Practical Contribution Practitioners, policymakers, and pharmaceutical firms will benefit from insights into the practical potential and limitations of blockchain adoption. The proposed framework may inform strategic decision-making, technology investment, and regulatory alignment. 8. Scope and Limitations Scope Focus on pharmaceutical supply chains Emphasis on transparency and traceability Analysis of blockchain as a technological enabler Limitations Reliance on secondary data and documented cases Limited availability of large-scale real-world implementations Rapid evolution of blockchain technology These limitations are acceptable given the exploratory and framework-development focus of the study. 9. Timeline and Work Plan Phase Activity Duration Phase 1 Proposal approval & refinement 2 weeks Phase 2 Literature review 6 weeks Phase 3 Data collection & case analysis 4 weeks Phase 4 Data analysis & framework development 4 weeks Phase 5 Writing & revisions 6 weeks Phase 6 Final submission 2 weeks 10. Expected Outcomes A completed master’s thesis meeting university standards A conceptual framework for blockchain-enabled pharmaceutical supply chain transparency Potential conference paper or journal article submission Practical recommendations for industry stakeholders Conclusion This proposal presents a well-structured, methodologically sound, and academically rigorous research plan that addresses a pressing challenge in pharmaceutical supply chain management. By critically examining blockchain technology’s role in enhancing transparency, the study positions itself as a valuable contribution to both scholarly discourse and industry practice, while remaining feasible within the constraints of a master’s final year project. If you would like, I can next: Adapt this to your university’s proposal template Add Harvard / APA citations Convert it into a defense-ready proposal document Narrow it to a specific country or regulatory context Strengthen it with hypotheses and variables for a quantitative version